EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of “Psychobiotics”

Stefania Garzone iD, Ioannis Alexandros Charitos iD, Manuela Mandorino iD, Maria Elena Maggiore iD, Loredana Capozzi iD, Bujar Cakani iD, Gabriel César Dias Lopes iD, Luisella Bocchio-Chiavetto iD, Marica Colella iD

International Journal of Molecular Sciences · 25.02.2025 · 26 (5) · 1972

DOI: 10.3390/ijms26051972 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.02.2025. Verfasst von Stefania Garzone und 8 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Department of Medicine, Section of Microbiology and Virology, School of Medicine, University of Bari, 70124 Bari, Italy. Hauptthemen laut MEDLINE: Brain, Mental Disorders, Probiotics, Affect. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychobiotics, live microorganisms that provide mental health by interacting with the gut microbiota, are emerging as a promising therapeutic option for psychiatric and neurodevelopmental disorders. Their effectiveness in addressing conditions such as depression, anxiety, insomnia, stress, autism spectrum disorder (ASD), and eating disorders were examined through a comprehensive analysis of existing studies up to the first half of 2024, based on data from reliable electronic databases. We found that psychobiotics can significantly reduce symptoms of various psychiatric disorders by influencing neurotransmitter levels, regulating the hypothalamic-pituitary-adrenal (HPA) axis, and improving gut barrier function through short-chain fatty acids (SCFAs) and other metabolites. However, several limitations were identified, including inconsistent study methodologies, small sample sizes, and a lack of data on long-term safety. Addressing these limitations through rigorous research is essential for establishing standardized protocols and fully confirming the therapeutic potential of psychobiotics. In conclusion, psychobiotics show great promise as complementary treatments for mental health conditions, but continued research is necessary to refine their application and integrate them into clinical practice effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrainMental DisordersProbioticsAffectHumansGastrointestinal MicrobiomeHypothalamo-Hypophyseal SystemAnimalsPituitary-Adrenal System

Stichwörter der Autor:innen

gut-brain axisneurodevelopmental disordersneurotransmittersprobioticspsychiatric disorders

Autor:innen und Institutionen

  • Interdisciplinary Department of Medicine, Section of Microbiology and Virology, School of Medicine, University of Bari, 70124 Bari, Italy.
  • Istituti Clinici Scientifici Maugeri IRCCS, Pneumology and Respiratory Rehabilitation Unit, "Institute" of Bari, 70124 Bari, Italy.
  • Istituto Zooprofilattico Sperimentale della Puglia e della Basilicata, 71121 Foggia, Italy.
  • Department of Clinical Disciplines, "Alexander Xhuvani" University of Elbasan, 3001 Elbasan, Albania.
  • Department of Neuroscience and Mental Health, School of Science of Health, Logos University International (UNILOGOS), Miami, FL 33137, USA.
  • Department of Neuroscience and Mental Health, School of Science of Health, European International University, 75018 Paris, France.

ORCID-Profile: Stefania Garzone, Ioannis Alexandros Charitos, Manuela Mandorino, Maria Elena Maggiore, Loredana Capozzi, Bujar Cakani, Gabriel César Dias Lopes, Luisella Bocchio-Chiavetto, Marica Colella

Zitieren

APA

Garzone, S., Charitos, I. A., Mandorino, M., Maggiore, M. E., Capozzi, L., Cakani, B., Dias Lopes, G. C., Bocchio-Chiavetto, L., & Colella, M. (2025). Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of “Psychobiotics”. International Journal of Molecular Sciences, 26(5), 1972. https://doi.org/10.3390/ijms26051972

Vancouver

Garzone S, Charitos IA, Mandorino M, Maggiore ME, Capozzi L, Cakani B, et al. Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of “Psychobiotics”. International Journal of Molecular Sciences. 2025;26(5):1972. doi:10.3390/ijms26051972

BibTeX
@article{Garzone2025,
  author = {Garzone, Stefania and Charitos, Ioannis Alexandros and Mandorino, Manuela and Maggiore, Maria Elena and Capozzi, Loredana and Cakani, Bujar and Dias Lopes, Gabriel César and Bocchio-Chiavetto, Luisella and Colella, Marica},
  title = {Can We Modulate Our Second Brain and Its Metabolites to Change Our Mood? A Systematic Review on Efficacy, Mechanisms, and Future Directions of “Psychobiotics”},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {1972},
  doi = {10.3390/ijms26051972}
}
Kostenlos starten →